Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001108205-25-000031
Filing Date
2025-03-31
Accepted
2025-03-31 16:04:23
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cris-20241231.htm   iXBRL 10-K 1832384
2 EX-4.2 cris-12312024x10kexx42.htm EX-4.2 27221
3 EX-10.23 a3rdnoticenq2010sipfullvst1.htm EX-10.23 43242
4 EX-10.27 curis_5thar2010planxisoagt.htm EX-10.27 18926
5 EX-10.28 curis_5thar2010planxnsoxdo.htm EX-10.28 17710
6 EX-19 curis-thirdrestatedinsider.htm EX-19 77263
7 EX-21 cris-12312024x10kexx21.htm EX-21 4015
8 EX-23.1 cris-12312024x10kexx231.htm EX-23.1 3035
9 EX-31.1 cris-12312024x10kexx311.htm EX-31.1 10839
10 EX-31.2 cris-12312024x10kexx312.htm EX-31.2 10789
11 EX-32.1 cris-12312024x10kexx321.htm EX-32.1 4863
12 EX-32.2 cris-12312024x10kexx322.htm EX-32.2 4801
13 EX-97 curisclawbackpolicy_adopte.htm EX-97 19707
19 image.jpg GRAPHIC 8417
20 image_0.jpg GRAPHIC 24655
21 image_0a.jpg GRAPHIC 29903
  Complete submission text file 0001108205-25-000031.txt   8084707

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20241231.xsd EX-101.SCH 57610
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cris-20241231_cal.xml EX-101.CAL 66099
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cris-20241231_def.xml EX-101.DEF 219164
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20241231_lab.xml EX-101.LAB 738280
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20241231_pre.xml EX-101.PRE 476038
99 EXTRACTED XBRL INSTANCE DOCUMENT cris-20241231_htm.xml XML 780486
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30347 | Film No.: 25793078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)